Review





Similar Products

92
Innovative Research Inc mouse serum albumin
Mouse Serum Albumin, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse serum albumin/product/Innovative Research Inc
Average 92 stars, based on 1 article reviews
mouse serum albumin - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

96
Equitech-Bio inc mouse plasma
Mouse Plasma, supplied by Equitech-Bio inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse plasma/product/Equitech-Bio inc
Average 96 stars, based on 1 article reviews
mouse plasma - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

90
DEMEDITEC Diagnostics GmbH enzyme immunoassay rat/mouse serum/plasma kit
Enzyme Immunoassay Rat/Mouse Serum/Plasma Kit, supplied by DEMEDITEC Diagnostics GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme immunoassay rat/mouse serum/plasma kit/product/DEMEDITEC Diagnostics GmbH
Average 90 stars, based on 1 article reviews
enzyme immunoassay rat/mouse serum/plasma kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

93
R&D Systems plasma
Plasma, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasma/product/R&D Systems
Average 93 stars, based on 1 article reviews
plasma - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Innovative Research Inc mouse serum albumin msa proteins
Mouse Serum Albumin Msa Proteins, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse serum albumin msa proteins/product/Innovative Research Inc
Average 92 stars, based on 1 article reviews
mouse serum albumin msa proteins - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

90
Millipore mouse sdf-1 alpha / cxcl12 alpha elisa kit, for serum, plasma, and cell culture
M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and <t>CXCL12</t> (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).
Mouse Sdf 1 Alpha / Cxcl12 Alpha Elisa Kit, For Serum, Plasma, And Cell Culture, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse sdf-1 alpha / cxcl12 alpha elisa kit, for serum, plasma, and cell culture/product/Millipore
Average 90 stars, based on 1 article reviews
mouse sdf-1 alpha / cxcl12 alpha elisa kit, for serum, plasma, and cell culture - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
PBL Assay mouse ifn beta elisa kit, high sensitivity (serum, plasma, tcm
M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and <t>CXCL12</t> (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).
Mouse Ifn Beta Elisa Kit, High Sensitivity (Serum, Plasma, Tcm, supplied by PBL Assay, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ifn beta elisa kit, high sensitivity (serum, plasma, tcm/product/PBL Assay
Average 90 stars, based on 1 article reviews
mouse ifn beta elisa kit, high sensitivity (serum, plasma, tcm - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Mercodia Inc serum (mouse), pancreatic perfusate, plasma (human) glucagon
M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and <t>CXCL12</t> (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).
Serum (Mouse), Pancreatic Perfusate, Plasma (Human) Glucagon, supplied by Mercodia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/serum (mouse), pancreatic perfusate, plasma (human) glucagon/product/Mercodia Inc
Average 90 stars, based on 1 article reviews
serum (mouse), pancreatic perfusate, plasma (human) glucagon - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
BioIVT Inc c57bl/6 mouse, cyno and human liver, serum, and plasma samples
M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and <t>CXCL12</t> (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).
C57bl/6 Mouse, Cyno And Human Liver, Serum, And Plasma Samples, supplied by BioIVT Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c57bl/6 mouse, cyno and human liver, serum, and plasma samples/product/BioIVT Inc
Average 90 stars, based on 1 article reviews
c57bl/6 mouse, cyno and human liver, serum, and plasma samples - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and CXCL12 (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).

Journal: Cell

Article Title: Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

doi: 10.1016/j.cell.2022.04.039

Figure Lengend Snippet: M-HSCT allows establishing sufficient donor chimerism to rescue the HIGM1 phenotype (A) Schematic of different mobilization protocols tested and the times of analysis in Cd40lg −/− mice. (B–D) Counts of mobilized WBC (B), LSK (C), and SLAM HSC (D) per mL in the PB of Cd40lg −/− mice treated with PBS (Sham), G-CSF for 7 days (G7), G-CSF for 7 days and AMD3100 (G7A), G-CSF for 7 days, AMD3100 and BIO5192 (G7AB), half-dose of G-CSF for 7 days, AMD3100 and BIO5192 (G7AB-H), G-CSF for 5 days and AMD3100 (G5A), G-CSF for 5 days, AMD3100 and BIO5192 (G5AB), G-CSF for 3 days, AMD3100 and BIO5192 (G3AB), half-dose of G-CSF for 3 days, AMD3100 and BIO5192 (G3AB-H), and only AMD3100 and BIO5192 (AB) at 0, 1, 3, 6, and 9 h after the last injection of A or AB. (E and F) MMP9 (E) and CXCL12 (F) concentration in the BM extracellular extracts of Cd40lg −/− mice mobilized with protocols described above. (G) Total counts of SLAM HSC in the lower limbs (left panel) and in the PB per mL (right panel) of Cd40lg −/− mice treated with PBS or mobilized with G7AB. (H) Long-term follow-up of the donor WT (blue) and recipient Cd40lg −/− (ocher) chimerism observed within total CD45 + cells in PB after transplanting 2 × 10 6 Lin − cells (collected from the BM) post mobilization in recipient Cd40lg −/− mice. (I–K) Myeloid and lymphoid lineage composition of Cd40lg −/− (left panel) and WT (right panel) cells in the PB (I), BM (J), and spleen (K) of Cd40lg −/− mice after M-HSCT. (L) TNP-KLH-specific IgG concentration in sera collected 7 days before (pre) and after (post) TNP-KLH vaccination of Cd40lg −/− mice after M-HSCT. (M) The percentage of PNA + GL7 + splenic germinal centers B cells within the spleen of Cd40lg −/− mice after TNP-KLH vaccination of Cd40lg −/− mice treated by M-HSCT. The results are mean ± SEM, with n ≧ 5 biological replicates for the kinetic experiments, except for the AB group (n = 4), and with n ≧ 9 biological replicates for the Cd40lg −/− M-HSCT experiments. In all the analyses, p less than 0.05 were considered significant (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. “ns” means non-significance).

Article Snippet: Mouse SDF-1 alpha / CXCL12 alpha ELISA Kit, for serum, plasma, and cell culture , Sigma-Aldrich , Cat# RAB0125-1KT.

Techniques: Injection, Concentration Assay

Journal: Cell

Article Title: Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells

doi: 10.1016/j.cell.2022.04.039

Figure Lengend Snippet:

Article Snippet: Mouse SDF-1 alpha / CXCL12 alpha ELISA Kit, for serum, plasma, and cell culture , Sigma-Aldrich , Cat# RAB0125-1KT.

Techniques: Blocking Assay, Plasmid Preparation, Recombinant, Electroporation, CRISPR, Enzyme-linked Immunosorbent Assay, Cell Culture, Expressing